Plasminogen activator inhibitor-1 and the risk of Type 2 diabetes mellitus in American Indians: The Strong Heart Study [1]

Diabetic Medicine

Volumn 23, Issue 10, 2006, Pages 1158-1159

  Davidson, M ^a   Zhu, J ^a   Lu, W ^a   Tracy, R P ^b   Robbins, D C ^c   Resnick, H E ^a   Ruotolo, G ^a   Howard, B V ^a  

^a MEDSTAR RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; GLUCOSE; INSULIN; ORAL ANTIDIABETIC AGENT; PLASMINOGEN ACTIVATOR INHIBITOR 1;

AMERICAN INDIAN; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR RISK; COHORT ANALYSIS; COMPARATIVE STUDY; CORRELATIONAL STUDY; DEMOGRAPHY; FIBRINOGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE TEST; HEART; HUMAN; IMMUNOASSAY; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LETTER; LONGITUDINAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PREVALENCE; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL;

DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; HUMANS; INDIANS, NORTH AMERICAN; INSULIN RESISTANCE; PLASMINOGEN ACTIVATOR INHIBITOR 1; RISK ASSESSMENT; RISK FACTORS; SERINE PROTEINASE INHIBITORS;

EID: 33748745007     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2006.01923.x     Document Type: Letter

References (6)

1. Kohler HP, Grant PJ. Plasminogen-activator inhibitor type 1 and coronary artery disease. N Engl J Med 2000; 342: 1792-1801.
2. Festa A, D'Agostina R, Mykkanen L, Tracy RP, Zaccaro DJ, Hales CN et al. Relative contribution of insulin and its precursors to fibrinogen and PAT-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS). Arterioscler Thromb Vase Bio1 1999; 19: 562-568.
3. Festa A, D'Agostina R, Tracy RP, Haffner SM. Elevated levels of acute-phase proteins and PAI-I predict the development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study. Diabetes 2002; 51: 1131-1137.
4. Lee ET, Welty TK, Fabsitz R, Cowan LD, Lee NA, Oopik AL et al. The Strong Heart Study. A study of cardiovascular disease in American Indians: design and methods. Am J Epidemio1 1990; 132: 1141-1155.
5. Lee ET, Howard BV, Savage PL, Cowan ED, Fabsitz RR, Oopik Al et al. Diabetes and impaired glucose tolerance in three American Indian populations aged 45-74 years. The Strong Heart Study. Diabetes Care 1995; 18: 599-610.
6. Welty TK, Lee ET, Yeh J, Cowan ED, Go O, Fabsitz RR et al. Cardiovascular disease risk factors among American Indians. The Strong Heart Study. Am J Epidemiol 1995; 142: 269-287.